Patents Assigned to Baxter Health S.A.
  • Diagnostic assay for anti-von Willebrand Factor cleaving protease (ADAMTS13) antibodies
    Patent number: 7943326
    Abstract: This invention relates to a kit to be used in an assay system for determination of an anti-von Willebrand Factor-cleaving protease (“anti-vWF-cp”) antibody in a sample. The kit comprises vWF-cp and/or vWF-fragment(s) immobilized on a solid phase. The kit can be used in a method for determination of anti-vWF-cp antibodies from a patient, for the diagnosis of disorders associated with the occurrence of anti-vWF-cp-antibodies, and the differentiation of various forms of thrombotic microangiopathy.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: May 17, 2011
    Assignees: Baxter Health S.A., Baxter International, Inc.
    Inventors: Friedrich Scheiflinger, Manfred Rieger, Barbara Plaimauer